Top Medical News

Rituximab Modulates Retinal Atrophy in Relapsing-Remitting Multiple Sclerosis

April 15, 2021

By Marco Meglio

Findings suggest that the neuroprotective therapeutic response from rituximab in patients with relapsing-remitting multiple sclerosis may take up to 12 months.

What to Expect from the 2021 American Academy of Neurology Annual Meeting

April 14, 2021

By Matt Hoffman

The 2021 AAN Annual Meeting will be held virtually from April 17-24. Follow along with coverage from NeurologyLive, including expert interviews and session recaps.

Minorites May Receive Less Timely MCI Diagnoses Than White Individuals

April 14, 2021

By Victoria Johnson

Researchers analyzed data from the 10,472 Medicare beneficiaries diagnosed with mild cognitive impairment or dementia in California.

NeuroVoices: Ralph Sacco, MD, MS, on Improving Disparities and Expanding Research in Stroke Care

April 14, 2021

By Marco Meglio

The chair of neurology and Olemberg Family Chair of Neurological Disorders at the University of Miami Miller School of Medicine discussed solutions to improve disparities in stroke care and the need for future research on social determinants of health.

Treating Paramagnetic Rim Lesions in Multiple Sclerosis

April 13, 2021

By Victoria Johnson

Jemima Akinsanya, DO, Neuroimmunology Clinical Fellow at the National Institutes of Health, discussed new studies of anakinra and tolebrutinib in MS.


Latest Videos

Most Recent